Detalles de la búsqueda
1.
Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study.
Diabetes Obes Metab
; 21(3): 648-657, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30370611
2.
Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes Study.
Intern Med J
; 48(10): 1215-1221, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29230931
3.
Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence.
Respirology
; 16(8): 1210-20, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21801275
4.
Degree-of-spread artefact in the New South Wales Central Cancer Registry.
Aust N Z J Public Health
; 32(5): 414-6, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18959542
5.
The relationship between intensification of blood glucose-lowering therapies, health status and quality of life in type 2 diabetes: The Fremantle Diabetes Study Phase II.
Diabetes Res Clin Pract
; 142: 294-302, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29879496
6.
Relationship between depression and diabetes in pregnancy: A systematic review.
World J Diabetes
; 7(19): 554-571, 2016 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27895824
7.
Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT.
Cancer Res Treat
; 47(3): 424-35, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25410761
8.
Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer.
Lung Cancer
; 85(3): 401-7, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25082564
9.
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: a randomised, phase 3 trial.
Eur J Cancer
; 50(13): 2219-30, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24953333
10.
Biostatistics primer: what a clinician ought to know--prognostic and predictive factors.
J Thorac Oncol
; 8(6): 808-13, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23676560
11.
Elderly subset analysis of randomized phase III study comparing pemetrexed plus carboplatin with docetaxel plus carboplatin as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer.
Drugs R D
; 13(4): 289-96, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24277116
12.
A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up.
Breast Cancer
; 20(4): 357-62, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22354450
13.
Smoking history as a predictive factor of treatment response in advanced non-small-cell lung cancer: a systematic review.
Clin Lung Cancer
; 13(4): 239-51, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22154074
14.
Biostatistics primer: what a clinician ought to know: hazard ratios.
J Thorac Oncol
; 6(6): 978-82, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21623277
15.
A systematic review of the interobserver variability for histology in the differentiation between squamous and nonsquamous non-small cell lung cancer.
J Thorac Oncol
; 6(1): 55-63, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21107286
16.
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
J Clin Oncol
; 29(13): 1678-85, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21444871
17.
A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer.
J Thorac Oncol
; 6(11): 1907-14, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22005471
18.
Biostatistics primer: what a clinician ought to know: subgroup analyses.
J Thorac Oncol
; 5(5): 741-6, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20421767
19.
Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB-IVA cervical cancer.
Gynecol Oncol Rep
; 10: 36-7, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26076001
20.
In response.
J Thorac Oncol
; 8(12): e116-7, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24389452